For fiscal 2025 (ended Dec 31, 2025), UBS Group AG Registered reported $49.57B of revenue and $7.80B of net income.
UBS revenue was $49.57B for fiscal 2025 (ended Dec 31, 2025), up 2.0% from fiscal 2024. Compound annual growth was +8.4% over 5 years. It rose in 7 of the last 9 fiscal years. Fiscal 2025 is the highest of the 10 fiscal years on file.
UBS net income was $7.80B for fiscal 2025 (ended Dec 31, 2025), up 51.5% from fiscal 2024. Compound annual growth was +3.5% over 5 years. It rose in 6 of the last 9 fiscal years.
UBS diluted EPS was $2.36 for fiscal 2025 (ended Dec 31, 2025), up 55.3% from fiscal 2024. Compound annual growth was +5.9% over 5 years.
| Line item | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $49.57B | $48.61B | $40.83B | $34.56B | $35.39B | $33.08B | $28.97B | $30.33B | $29.75B | $28.77B |
| Selling, general and admin | $8.81B | $10.12B | $10.16B | $5.19B | $5.55B | $4.88B | $5.29B | $6.80B | $6.95B | $7.52B |
| Pre-tax income | $8.85B | $6.82B | $28.25B | $9.60B | $9.48B | $8.15B | $5.58B | $5.99B | $5.35B | $4.21B |
| Income tax | $1.06B | $1.68B | $873.00M | $1.94B | $2.00B | $1.58B | $1.27B | $1.47B | $4.30B | $777.00M |
| Net income | $7.80B | $5.15B | $27.38B | $7.66B | $7.49B | $6.57B | $4.31B | $4.52B | $1.05B | $3.43B |
| EPS, basic | $2.46 | $1.59 | $8.68 | $2.34 | $2.14 | $1.83 | $1.17 | $1.21 | $0.26 | $0.90 |
| EPS, diluted | $2.36 | $1.52 | $8.30 | $2.25 | $2.06 | $1.77 | $1.14 | $1.18 | $0.25 | $0.88 |
| Diluted shares | 3.29B | 3.35B | 3.30B | 3.40B | 3.63B | 3.71B | 3.77B | 3.84B | 3.84B | 3.82B |
| Line item | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | $231.38B | $244.09B | $340.21B | $195.32B | $207.88B | $173.53B | $119.87B | $126.08B | $104.83B | $119.01B |
| Goodwill | $6.10B | $6.00B | $6.00B | $6.00B | $6.10B | - | - | - | - | - |
| Total assets | $1.62T | $1.57T | $1.72T | $1.10T | $1.12T | $1.13T | $972.19B | $958.50B | $939.28B | $918.91B |
| Total liabilities | $1.53T | $1.48T | $1.63T | $1.05T | $1.06T | $1.07T | $917.52B | $905.43B | $886.73B | $865.32B |
| Shareholders' equity | $90.21B | $85.08B | $86.16B | $57.22B | $61.00B | $59.77B | $54.67B | $53.06B | $52.49B | $52.92B |
| Line item | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $21.85B | $3.28B | $86.07B | $14.65B | $31.43B | $36.96B | $19.70B | $28.91B | -$52.10B | -$18.29B |
| Investing cash flow | -$22.80B | $709.00M | $103.12B | -$12.45B | -$2.12B | -$6.79B | -$1.56B | -$6.13B | $5.19B | $36.64B |
| Financing cash flow | -$30.86B | -$84.17B | -$58.26B | -$9.09B | $10.35B | $12.43B | -$25.61B | $190.00M | $26.99B | -$612.00M |
| Line item | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth, YoY | 2.0% | 19.0% | 18.1% | -2.3% | 7.0% | 14.2% | -4.5% | 1.9% | 3.4% | - |
| Net income growth, YoY | 51.5% | -81.2% | 257.4% | 2.3% | 13.9% | 52.5% | -4.7% | 332.3% | -69.5% | - |
| EPS growth, YoY | 55.3% | -81.7% | 268.9% | 9.2% | 16.4% | 55.3% | -3.4% | 372.0% | -71.6% | - |
| Net margin | 15.7% | 10.6% | 67.1% | 22.2% | 21.2% | 19.9% | 14.9% | 14.9% | 3.5% | 11.9% |
| Return on equity | 8.6% | 6.0% | 31.8% | 13.4% | 12.3% | 11.0% | 7.9% | 8.5% | 2.0% | 6.5% |
| Return on assets | 0.5% | 0.3% | 1.6% | 0.7% | 0.7% | 0.6% | 0.4% | 0.5% | 0.1% | 0.4% |
Source: XBRL data UBS Group AG Registered files with the SEC, latest filing dated Mar 9, 2026 (see filings on SEC EDGAR). Provided for information only, not investment advice. Check the filing before relying on a number.
Per-share figures are as filed. The filings show no stock split in these periods.
EPS growth is left out where the share count moved enough to suggest a split the filings do not show. Growth rates need a positive starting figure. CAGR is compound annual growth between fiscal years. The CSV holds every period on file, in full figures, from the same SEC filings.
Foreign private issuers file annual reports with the SEC, so there are no quarterly statements here.
| Company | Revenue | Growth | Net income | Net margin | Market cap |
|---|---|---|---|---|---|
| UBS | $49.57B | +2.0% | $7.80B | 15.7% | $148.27B |
| JPM | $203.15B | +13.2% | $65.98B | 32.5% | $888.26B |
| BAC | $120.16B | +5.4% | $32.24B | 26.8% | $340.97B |
| WFC | $87.23B | +5.4% | $22.97B | 26.3% | $251.98B |
| C | $85.22B | +5.6% | $14.31B | 16.8% | $199.70B |
| COF | $63.01B | +31.2% | $10.87B | 17.2% | $121.43B |
| MFG | ¥8.79T | +7.6% | ¥1.16T | 13.2% | $116.96B |
| BNS | C$37.74B | +12.1% | C$7.79B | 20.6% | $112.48B |
| BNY | $21.96B | +11.2% | $6.54B | 29.8% | $99.40B |